Monoclonal Antibodies to the V2 Domain of MN-rgp120: Fine Mapping of Epitopes and Inhibition of [alpha]4[beta]7 Binding
Recombinant gp120 (MN-rgp120) was a major component of the AIDSVAX B/E vaccine used in the RV144 trial. This was the first clinical trial to show that vaccination could prevent HIV infection in humans. A recent RV144 correlates of protection study found that protection correlated with the presence o...
Saved in:
Published in | PloS one Vol. 7; no. 6; p. e39045 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Public Library of Science
13.06.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!